S-K 1603, SPAC Sponsor; Conflicts of Interest |
May 26, 2026 |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Spac Sponsor Its Affiliates And Promoters Line Items | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| SPAC Sponsor and Affiliates Information, Restrictions on Sale of SPAC Securities [Table Text Block] | Pursuant to a letter agreement to be entered with us, each of our initial shareholders, including our sponsor, and our directors and officers, has agreed to certain restrictions on such party’s ability to transfer, assign or sell the founder shares and private placement shares to unaffiliated parties, as summarized in the table below.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fiduciary Duties to Other Companies, SPAC Officers and Directors [Table Text Block] | Below
is a table summarizing the entities to which our officers, directors and director nominees currently have fiduciary duties or contractual
obligations which will take priority over us.
|